Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neurofibromatosis 1 × Sarcoma × Clear all

Phase

Phase 2 3 Phase 1/2 1 Phase 1 1

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 7 Sarcoma 1 Other hematologic neoplasm 1

Conditions

Sarcoma 136 Glioblastoma 78 Gliosarcoma 72 Brain Neoplasms 49 Central Nervous System Neoplasms 45 Osteosarcoma 40 Sarcoma, Ewing 38 Astrocytoma 35 Rhabdomyosarcoma 32 Neuroblastoma 28 Neoplasms 28 Neoplasm Metastasis 28 Lymphoma 28 Glioma 28 Oligodendroglioma 27 Melanoma 26 Breast Neoplasms 25 Ovarian Neoplasms 24 Colorectal Neoplasms 23 Recurrence 22 Dendritic Cell Sarcoma, Interdigitating 22 Lymphoma, Non-Hodgkin 21 Carcinoma, Non-Small-Cell Lung 20 Stomach Neoplasms 19 Lymphoma, Follicular 18 Lymphoma, Large B-Cell, Diffuse 17 Carcinoma, Renal Cell 17 Burkitt Lymphoma 17 Liposarcoma 16 Leukemia 16

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06735820 2025-07-03

MEKMDM2

Children's National Research Institute

Phase 1/2 Not yet recruiting

Neurofibromatosis 1, Neurofibrosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡